| 328 Preclinical analyses and proof of concept clinical study of Epstein Barr Virus (EBV) specific genetically modified T cells against EBV associated malignancies XF Chen, D Wang, J Huan, X Zhang, L Li, XI Zhang, R Stripecke, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| T cell differentiation and lineage choice are determined by the TCR J Miles, T Watkins, S Darko, K Wijaya, M Cooper, A Ransier, ... The FASEB Journal 36, 2022 | | 2022 |
| Estimating the global burden of Epstein–Barr virus-related cancers Y Wong, MT Meehan, SR Burrows, DL Doolan, JJ Miles Journal of Cancer Research and Clinical Oncology, 1-16, 2022 | 130 | 2022 |
| T-Cell Receptors and Uses Thereof SR Burrows, JM Burrows, PL Groves US Patent App. 17/288,524, 2021 | | 2021 |
| Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cells T Nishimura, H Xu, M Iwasaki, D Karigane, B Saavedra, Y Takahashi, ... Gene Therapy 27 (10), 525-534, 2020 | 12 | 2020 |
| Unique cellular immunity resides at the human fetomaternal interface T Watkins, H McGuire, B Santner-Nanan, A Ransier, M Hu, S Darko, ... European Journal of Immunology 49, 651-651, 2019 | | 2019 |
| The early proximal αβ TCR signalosome specifies thymic selection outcome through a quantitative protein interaction network SC Neier, A Ferrer, KM Wilton, SEP Smith, AMH Kelcher, KD Pavelko, ... Science immunology 4 (32), eaal2201, 2019 | 17 | 2019 |
| Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis MP Pender, PA Csurhes, C Smith, NL Douglas, MA Neller, KK Matthews, ... JCI insight 3 (22), 2018 | 144 | 2018 |
| Peptide mimic for influenza vaccination using nonnatural combinatorial chemistry JJ Miles, MP Tan, G Dolton, ESJ Edwards, SAE Galloway, B Laugel, ... The Journal of clinical investigation 128 (4), 1569-1580, 2018 | 28 | 2018 |
| Autoreactive CD8+ T-cells are highly dependent on CD8 for activation and as such targeting CD8 is an effective way of blocking autoreactive CD8+ T-cell activation L Wooldridge, D Morgan, JA Pearson, S Gras, H van den Berg, A Lissina, ... The Journal of Immunology 198 (1_Supplement), 127.26-127.26, 2017 | | 2017 |
| Allelic Polymorphism in the T-Cell Receptor Genes and Its Impact on T-Cell Alloreactivity S Burrows, RM Engel Transplantation 101 (5S-3), S64, 2017 | | 2017 |
| Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosis MP Pender, PA Csurhes, C Smith, NL Douglas, MA Neller, L Beagley, ... Multiple Sclerosis Journal 23, 401-401, 2017 | 4 | 2017 |
| Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of … M Pender, P Csurhes, C Smith, N Douglas, M Neller, L Beagley, S Rehan, ... Neurology 89 (8), E103-E103, 2017 | 2 | 2017 |
| Defective T‐cell control of Epstein–Barr virus infection in multiple sclerosis MP Pender, PA Csurhes, JM Burrows, SR Burrows Clinical & translational immunology 6 (1), e126, 2017 | 145 | 2017 |
| CD8+ T‐cell specificity is compromised at a defined MHCI/CD8 affinity threshold T Dockree, CJ Holland, M Clement, K Ladell, JE McLaren, ... Immunology and cell biology 95 (1), 68-76, 2017 | 22 | 2017 |
| Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies M Clement, JA Pearson, S Gras, HA Van Den Berg, A Lissina, ... Scientific reports 6 (1), 35332, 2016 | 28 | 2016 |
| Coinfection with human cytomegalovirus genetic variants in transplant recipients and its impact on antiviral T cell immune reconstitution C Smith, RM Brennan, SK Tey, MJ Smyth, SR Burrows, JJ Miles, GR Hill, ... Journal of virology 90 (16), 7497-7507, 2016 | 9 | 2016 |
| Targeting EBV positive cancers with affinity enhanced T cell receptors Y Wong, E Gostick, M Lomax, A Vuidepot, E Baston, W Shingler, ... EUROPEAN JOURNAL OF IMMUNOLOGY 46, 1212-1212, 2016 | | 2016 |
| The TCR signalosome specifies thymic selection outcome by a quantitative network mechanism that sums activity across a single protein-interaction signature A Schrum, S Neier, S Smith, A Ferrer, K Wilton, Z Chen, J McCluskey, ... European Journal of Immunology 46, 260-261, 2016 | | 2016 |
| Engineering of isogenic cells deficient for MR1 with a CRISPR/Cas9 lentiviral system: Tools to study microbial antigen processing and presentation to human MR1-restricted T cells B Laugel, A Lloyd, EW Meermeier, MD Crowther, TR Connor, G Dolton, ... The Journal of Immunology 197 (3), 971-982, 2016 | 34 | 2016 |
